Global Continuous Renal Replacement Therapy Market is set to exceed USD 1.3 billion by 2024; according to a new research report by Global Market Insights, Inc. Rising prevalence of chronic kidney disorders will augment the CRRT market growth during the forecast timeframe. According to National Kidney Foundation, around 10% of population suffers from chronic renal diseases and over millions of them die every year globally. Favorable regulations by regulatory bodies such as FDA enforce certain laws on manufacturers that ensures availability of superior quality CRRT devices in intensive care units thereby augmenting CRRT industry growth in foreseeable future.
Increasing R&D efforts by market leaders such as Asahi Kasei, Baxter, Fresenius Kabi and B.Braun have improved medical systems used in the continuous renal replacement therapy. For instance, Diapact CRRT system developed by B.Braun is integrated with advanced technology that enables efficient treatment of acute kidney diseases and injuries. The acute blood filtration process is carried out accurately without any obstructions ensuring faster recovery of patients. Improvements in the CRRT systems will ultimately favor continuous renal replacement therapy market growth. However, high costs of the CRRT systems may hamper the business growth in future.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2998
Continuous venovenous hemodiafiltration (CVVHDF) segment accounted for 29.6% in 2017. High revenue share is attributed to the preference for this modality amongst geriatric population owing to ease and convenience associated with it. The therapy is utilized in patients with multisystem organ failure or acute renal failure. CVVHDF is a slow continuous form of intermittent dialysis that enables quick patient recovery by maintaining electrolyte balance in the body.
Slow Continuous Ultrafiltration (SCUF) segment will witness 6.4% CAGR during the forecast timeframe. SCUF is mostly preferred by patients suffering from cardiac failure and blood pressure problems. There is a considerable reduction in the blood urea and creatinine levels after undergoing continuous slow ultrafiltration treatment. Increasing geriatric population in developed as well as developing economies that suffers from cardiac arrest due to kidney failure will boost Continuous Renal Replacement Therapy Market growth over the upcoming years.
Instruments segment will experience robust 7.3% CAGR during forecast timeframe. The segmental growth is attributable to rising preference for CRRT. Major players focus their efforts on developing new technologically advanced CRRT system. These innovations introduced within the CRRT systems enable faster patient recovery and thus, increased adoption of these instruments enhancing segmental growth.
Consumables segment was valued at USD 500.7 million in 2017. CRRT involves use of consumables such as catheters and blood tube sets that are utilized in blood purification process. CRRT demands frequent replacement of consumables as reusing these consumables may lead to complications. High replacement rate coupled with increasing demand for CRRT therapies will augment the usage of consumables rendering positive impact on Continuous Renal Replacement Therapy Market growth.
U.S. continuous renal replacement therapy market will experience 7.4% CAGR during the forecast timeframe and increasing elderly population base will further enhance business growth in near future. Incidences of chronic kidney diseases and acute kidney injuries is high amongst the geriatric population. According to Kidney News, population in the age group of 65 years and above have high chances of acquiring end stage renal diseases (ESRD). Moreover, rising government initiatives that help in reducing the cost of therapies will positively influence CRRT industry growth
Japan continuous renal replacement therapy market was valued at USD 59.0 million and is expected to grow further due to rising prevalence of diabetes and obesity that interferes with normal kidney functioning. According to International Japanese Federation, there were around 7.2 billion people detected with diabetes in 2017. Majority of them suffer from loss of one or more kidney functions due to hormonal imbalance that affects the kidney functions. Aforementioned factors along with adoption of advanced technology by majority of industry players such as Toray based in Japan will enhance the business growth in forthcoming years.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2998
Prominent industry players operational in the Continuous Renal Replacement Therapy Market include Asahi Kasei Corporation, B.Braun Melsungen, Baxter International, Fresenius Medical Care, Infomed, Medica, Medical Components, Medites, Medtronic, Nikkiso, Nxtstage, Toray. These industry players implement certain strategic initiatives such as mergers and acquisitions that help them in maintaining their market position. For instance, Fresenius Medical Care undertakes certain decision such as innovations in medical devices used in the acute therapy. It recently developed multiFiltratePRO system that is used in efficient treatment of acute kidney diseases. Development of such new products will ensure sustainable profits for the company.